Plain-English translation of NCT06621264 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a simple home-based walking program can help people who have both chronic kidney disease (stages 3–4) and peripheral artery disease—a condition where blood flow to the legs is reduced. Half of the participants will follow a structured 6-month walking program with guidance from a metronome app, while the other half will receive usual medical care. The researchers believe that regular, controlled walking may improve how far you can walk, strengthen your leg circulation, and reduce your risk of serious heart problems.
People with both kidney disease and poor leg blood circulation face a very high risk of heart attacks, strokes, and even amputation. Many of these patients are too sedentary because of pain or fear, which makes their conditions worse. This trial exists to find out if a simple, safe walking program done at home can help break that cycle and improve both mobility and survival.
You likely qualify if…
You likely don't qualify if…
If you join the walking group, you will do two 10-minute walking sessions per day at home for 6 months, using a digital metronome app to keep pace. The walking speed will start at about half your normal pace and gradually increase each week. You will visit the hospital at the start, at 1 month, at 3 months, and at the end (6 months) so doctors can check your progress and adjust your program. The control group will continue with their usual medical care and will also have study visits to measure outcomes.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Italy